COVID-19 Outbreak Information –

Beat In-Albon

Independent Member of the Board of Directors of PolyPeptide Group

Beat In-Albon, Independent Member of the Board of Directors of PolyPeptide Group, is a Swiss citizen born in 1952. Mr. In-Albon is the Chairman of Escientia Switzerland AG, Muttenz (since 2020) and of Evolva Holding SA, Reinach (since 2020). He further serves as non-executive Board member of Deccan Fine Chemicals Pvt. Ltd. (India) (since 2019). From 2016 to 2018, Mr. In-Albon was Head of Strategic Projects at Lonza Group AG, Basel on a part-time basis, after having served as Senior Vice President and Chief Operating Officer Specialty Ingredients and member of the Executive Management Committee from 2012 until 2015. Previously at Lonza, he held various positions starting 1983, including the role as Head of Organic Fine- & Performance Chemicals and member of the Executive Management Committee at Lonza Group AG between 2003 and 2006. Between 2007 and 2012, Mr. In-Albon served in different positions at SGS SA, Geneva, including as member of the Operations Council. Between 2009 and 2012 he served as a non-executive member of the Board of Directors of Siegfried AG, Zofingen. Mr. In-Albon holds a PhD in Economic Science from the University of Fribourg and a Master of Business Administration in Political Economy from the University of Fribourg.